183 related articles for article (PubMed ID: 11906651)
1. A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis.
Nagle TM; Torres SM; Horne KL; Grover R; Stevens MT
Vet Dermatol; 2001 Oct; 12(5):265-74. PubMed ID: 11906651
[TBL] [Abstract][Full Text] [Related]
2. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis.
Saevik BK; Bergvall K; Holm BR; Saijonmaa-Koulumies LE; Hedhammar A; Larsen S; Kristensen F
Vet Dermatol; 2004 Jun; 15(3):137-45. PubMed ID: 15214949
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
5. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
Marsella R; Nicklin CF; Saglio S; Lopez J
Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481
[TBL] [Abstract][Full Text] [Related]
6. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of AHR-13268, an antiallergenic compound, in the management of pruritus caused by atopic disease in dogs.
DeBoer DJ; Moriello KA; Pollet RA
Am J Vet Res; 1992 Apr; 53(4):532-6. PubMed ID: 1350185
[TBL] [Abstract][Full Text] [Related]
9. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitis.
Müller MR; Linek M; Löwenstein C; Röthig A; Doucette K; Thorstensen K; Mueller RS
Vet J; 2016 Apr; 210():77-81. PubMed ID: 26975448
[TBL] [Abstract][Full Text] [Related]
11. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Horvath-Ungerboeck C; Thoday KL; Shaw DJ; van den Broek AH
Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
[TBL] [Abstract][Full Text] [Related]
12. Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study.
Marsella R; Nicklin CF
Vet Dermatol; 2002 Aug; 13(4):203-10. PubMed ID: 12174182
[TBL] [Abstract][Full Text] [Related]
13. Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis.
Crow DW; Marsella R; Nicklin CF
Vet Dermatol; 2001 Aug; 12(4):189-95. PubMed ID: 11493402
[TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind clinical trial: Comparison of oclacitinib with a traditional Chinese herbal medicine product (Dihuang Guiqin capsule) in the treatment of canine atopic dermatitis.
Qin JJ; Zhu H; Song ZW; Hou XJ; Wang XM; Wang L; Li JX
Res Vet Sci; 2024 May; 171():105221. PubMed ID: 38490043
[TBL] [Abstract][Full Text] [Related]
16. The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.
Marsella R; Nicklin CF; Melloy C
Vet Dermatol; 2002 Jun; 13(3):131-9. PubMed ID: 12074702
[TBL] [Abstract][Full Text] [Related]
17. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Hon KL; Leung TF; Ng PC; Lam MC; Kam WY; Wong KY; Lee KC; Sung YT; Cheng KF; Fok TF; Fung KP; Leung PC
Br J Dermatol; 2007 Aug; 157(2):357-63. PubMed ID: 17501956
[TBL] [Abstract][Full Text] [Related]
19. Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial.
Hsiao YH; Chen C; Willemse T
J Vet Sci; 2016 Dec; 17(4):549-553. PubMed ID: 27297415
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
